Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Submitted by
admin
on April 22, 2013 - 10:23am
Source:
Forbes
News Tags:
Pharma CEOs
Sanofi
Eli Lilly
Alzheimer's disease
R&D
Chris Viehbacher
Headline:
Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Do Not Allow Advertisers to Use My Personal information
